A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
JournalAmerican Journal of Hematology
DOIs
StateAccepted/In press - Jan 1 2019

ASJC Scopus subject areas

  • Hematology

Cite this